<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Saclay_Notebook_September_12 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Saclay/Notebook/September/12</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container-fluid nav-container"><NAV class="navbar navbar-default navbar-inverse affix-top" data-spy="affix" data-offset-top="260"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav center-block"><LI><A href="https://2016.igem.org/Team:Paris_Saclay">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Media">Media</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Acknowledgements">Acknowledgements</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Background">Background</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Design">Design</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Experiments">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Perspective">Perspective</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Interlab_Study">Interlab Study</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Basic_Part">Basic Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Pratices </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Silver">Societal Issues of CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Gold">Responsible Research and Innovation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices/GMO_Regulation">GMO regulation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Safety">Safety</A></LI></DIV></DIV></NAV></DIV><DIV class="container content"><DIV id="main"><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Monday_12th_September"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Monday 12<SUP>th</SUP> September</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Visualization"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Visualization</SPAN></A></LI><LI class="toclevel-3 tocsection-3"><A href="#Glycerol_stocks_of_clones_4.2C_9.2C_13_and_16_containing_FRB_-_GFP11_in_pSB1C3_.28pPS16_019.29"><SPAN class="tocnumber">1.1.1</SPAN><SPAN class="toctext">Glycerol stocks of clones 4, 9, 13 and 16 containing FRB - GFP11 in pSB1C3 (pPS16_019)</SPAN></A></LI><LI class="toclevel-3 tocsection-4"><A href="#Plasmids_extraction_of_clones_4.2C_9.2C_13_and_16_containing_FRB_-_GFP11_in_pSB1C3_.28pPS16_019.29"><SPAN class="tocnumber">1.1.2</SPAN><SPAN class="toctext">Plasmids extraction of clones 4, 9, 13 and 16 containing FRB - GFP11 in pSB1C3 (pPS16_019)</SPAN></A></LI><LI class="toclevel-3 tocsection-5"><A href="#Samples_preparation_for_sequencing"><SPAN class="tocnumber">1.1.3</SPAN><SPAN class="toctext">Samples preparation for sequencing</SPAN></A></LI><LI class="toclevel-3 tocsection-6"><A href="#NanoDrop_Measurements"><SPAN class="tocnumber">1.1.4</SPAN><SPAN class="toctext">NanoDrop Measurements</SPAN></A></LI><LI class="toclevel-3 tocsection-7"><A href="#Gibson_of_cleaned_up_PCR_products_GFP_1.9_from_9th_September_x_pSB1C3_treated_by_DpnI_from_22nd_August"><SPAN class="tocnumber">1.1.5</SPAN><SPAN class="toctext">Gibson of cleaned up PCR products GFP 1.9 from 9th September x pSB1C3 treated by DpnI from 22nd August</SPAN></A></LI><LI class="toclevel-3 tocsection-8"><A href="#Transformation_of_DH5a_cells_with_GFP_1.9_in_pSB1C3_.28pPS16_020.29_obtained_by_Gibson"><SPAN class="tocnumber">1.1.6</SPAN><SPAN class="toctext">Transformation of DH5a cells with GFP 1.9 in pSB1C3 (pPS16_020) obtained by Gibson</SPAN></A></LI><LI class="toclevel-3 tocsection-9"><A href="#gblock_1.1_-_1.2_and_gblock_2.1_-_2.2_Ligation"><SPAN class="tocnumber">1.1.7</SPAN><SPAN class="toctext">gblock 1.1 - 1.2 and gblock 2.1 - 2.2 Ligation</SPAN></A></LI><LI class="toclevel-3 tocsection-10"><A href="#Clean-up_of_Ligation_products"><SPAN class="tocnumber">1.1.8</SPAN><SPAN class="toctext">Clean-up of Ligation products</SPAN></A></LI><LI class="toclevel-3 tocsection-11"><A href="#NanoDrop_Measurements_2"><SPAN class="tocnumber">1.1.9</SPAN><SPAN class="toctext">NanoDrop Measurements</SPAN></A></LI><LI class="toclevel-3 tocsection-12"><A href="#PCR_of_cleaned_up_Ligation_products_.28fragment_1_and_fragment_2.29_with_3.25_DMSO"><SPAN class="tocnumber">1.1.10</SPAN><SPAN class="toctext">PCR of cleaned up Ligation products (fragment 1 and fragment 2) with 3% DMSO</SPAN></A></LI><LI class="toclevel-3 tocsection-13"><A href="#Gel_of_PCR_products"><SPAN class="tocnumber">1.1.11</SPAN><SPAN class="toctext">Gel of PCR products</SPAN></A></LI></UL></DIV><H1><SPAN class="mw-headline" id="Monday_12th_September">Monday 12<SUP>th</SUP> September</SPAN></H1><H3><SPAN class="mw-headline" id="Visualization">Visualization</SPAN></H3><H4><SPAN class="mw-headline" id="Glycerol_stocks_of_clones_4.2C_9.2C_13_and_16_containing_FRB_-_GFP11_in_pSB1C3_.28pPS16_019.29">Glycerol stocks of clones 4, 9, 13 and 16 containing FRB - GFP11 in pSB1C3 (pPS16_019)</SPAN></H4><P>&quot;By Maxence &amp; Mahnaz&quot;
</P><P>The glycerol stock of the bacteria with the following plasmids were made.
</P><UL><LI>pPS16_019 (FRB - GFP11) clone 4</LI><LI>pPS16_019 (FRB - GFP11) clone 9</LI><LI>pPS16_019 (FRB - GFP11) clone 13</LI><LI>pPS16_019 (FRB - GFP11) clone 16</LI></UL><P>500µL of liquid culture and 250 µL of glycerol 60% were mixed and put at -20°C.
</P><H4><SPAN class="mw-headline" id="Plasmids_extraction_of_clones_4.2C_9.2C_13_and_16_containing_FRB_-_GFP11_in_pSB1C3_.28pPS16_019.29">Plasmids extraction of clones 4, 9, 13 and 16 containing FRB - GFP11 in pSB1C3 (pPS16_019)</SPAN></H4><P>&quot;By Maxence &amp; Mahnaz&quot;
</P><P>The following plasmids were extracted using the <A href="/Team:Paris_Saclay/Experiments#InvitrogenPlasmidExtraction" title="Team:Paris Saclay/Experiments">&quot;Charge Switch-Pro Plasmid Miniprep&quot;</A> kit:
</P><UL><LI>pPS16_019 (FRB - GFP11) clone 4</LI><LI>pPS16_019 (FRB - GFP11) clone 9</LI><LI>pPS16_019 (FRB - GFP11) clone 13</LI><LI>pPS16_019 (FRB - GFP11) clone 16</LI></UL><H4><SPAN class="mw-headline" id="Samples_preparation_for_sequencing">Samples preparation for sequencing</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>20 µL of plasmids pSB1C3 FRB - GFP 11 (pPS16_019) (clones 4, 9, 13 and 16) were sent to be sequenced. 20 µL of the primers iPS83 (5µM) and iPS84 (5µM) were sent for sequencing.
</P><H4><SPAN class="mw-headline" id="NanoDrop_Measurements">NanoDrop Measurements</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><TABLE class="wikitable"><TBODY><TR><TH>Sample
</TH><TH>Concentration (ng/µL)
</TH></TR><TR><TD>FRB - GFP 11 clone 4</TD><TD>96.29
</TD></TR><TR><TD>FRB - GFP 11 clone 9</TD><TD>35.51
</TD></TR><TR><TD>FRB - GFP 11 clone 13</TD><TD>79.91
</TD></TR><TR><TD>FRB - GFP 11 clone 16</TD><TD>50.58
</TD></TR><TR><TD>PCR product GFP 1.9 from 9th September</TD><TD>438.11
</TD></TR><TR><TD>pSB1C3 from 22nd August</TD><TD>31.61
</TD></TR><TR><TD>PCR fragment gblock 1.1 from 9th September</TD><TD>239.41
</TD></TR><TR><TD>PCR fragment gblock 1.2 from 9th September</TD><TD>195.92
</TD></TR><TR><TD>PCR fragment gblock 2.1 from 9th September</TD><TD>165.99
</TD></TR><TR><TD>PCR fragment gblock 2.2 from 9th September</TD><TD>143.45
</TD></TR></TBODY></TABLE><H4><SPAN class="mw-headline" id="Gibson_of_cleaned_up_PCR_products_GFP_1.9_from_9th_September_x_pSB1C3_treated_by_DpnI_from_22nd_August">Gibson of cleaned up PCR products GFP 1.9 from 9th September x pSB1C3 treated by DpnI from 22nd August</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>Gibson was performed with cleaned up PCR products GFP 1.9 (insert) (obtained the 9th September) x pSB1C3 treated by DpnI (plasmid) (obtained the 22nd August) with the following protocol:
</P><P>For each 20μl of reaction, mix the following reagents :
</P><UL><LI> 0.2 µL of insert</LI><LI> 3.16 µL of plasmid</LI><LI> 6.64 µL of water</LI><LI> 10 µL of buffer mix</LI></UL><P>Two controls were done: one without insert and one without buffer (water was added in order to have a total of 20 µL). The PCR was performed as follow : 1 hour at 50°C.
</P><H4><SPAN class="mw-headline" id="Transformation_of_DH5a_cells_with_GFP_1.9_in_pSB1C3_.28pPS16_020.29_obtained_by_Gibson">Transformation of DH5a cells with GFP 1.9 in pSB1C3 (pPS16_020) obtained by Gibson</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>Dh5a cells were transformed with pSB1C3 containing GFP 1.9, or controls (no buffer mix and plasmid alone) using the usual <A href="/Team:Paris_Saclay/Experiments#heat-shocktransformation" title="Team:Paris Saclay/Experiments">protocol</A>.
</P><H4><SPAN class="mw-headline" id="gblock_1.1_-_1.2_and_gblock_2.1_-_2.2_Ligation">gblock 1.1 - 1.2 and gblock 2.1 - 2.2 Ligation</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>gBlocks pPS16_001 and pPS16_002 were ligated together as following :
</P><UL><LI> 8 µL of pPS16_001 PCR product from 9th September</LI><LI> 8 µL of pPS16_002 PCR product from 9th September</LI><LI> 2 µL of Buffer T4 10X</LI><LI> 2 µL of ligase T4 enzyme</LI></UL><P>This strategy aims to obtain fragment 1.
</P><P>gBlocks pPS16_003 and pPS16_004 were ligated together as following :
</P><UL><LI> 8 µL of pPS16_003 PCR product from 9th September</LI><LI> 8 µL of pPS16_004 PCR product from 9th September</LI><LI> 2 µL of Buffer T4 10X</LI><LI> 2 µL of ligase T4 enzyme</LI></UL><P>This strategy aims to obtain fragment 2.
</P><P>The ligation product was put at rooming temperature for 2 hours.
</P><H4><SPAN class="mw-headline" id="Clean-up_of_Ligation_products">Clean-up of Ligation products</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>Ligation products obtained were cleaned up by using the NucleoSpin Gel and PCR Clean-up kit <A href="/Team:Paris_Saclay/Experiments#Purification" title="Team:Paris Saclay/Experiments">protocol</A>.
</P><H4><SPAN class="mw-headline" id="NanoDrop_Measurements_2">NanoDrop Measurements</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><TABLE class="wikitable"><TBODY><TR><TH>Sample
</TH><TH>Concentration (ng/µL)
</TH></TR><TR><TD>gblock 1.1 and gblock 1.2 cleaned-up Ligation product</TD><TD>194
</TD></TR><TR><TD>gblock 2.1 and gblock 2.2 cleaned-up Ligation product</TD><TD>157
</TD></TR></TBODY></TABLE><H4><SPAN class="mw-headline" id="PCR_of_cleaned_up_Ligation_products_.28fragment_1_and_fragment_2.29_with_3.25_DMSO">PCR of cleaned up Ligation products (fragment 1 and fragment 2) with 3% DMSO</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>As the annealing temperature (Tm) seems too high to obtain good results for fragments 1 and 2 amplification, DMSO was used in order to reduce the annealing temperature during the PCR. For that purpose, PCR was performed with the following protocol.
</P><P>For each 50μl of reaction, mix the following reagents :
</P><UL><LI> 1 µL of matrix</LI><LI> 1 µL of dNTPs (10mM)</LI><LI> 2.5 µL of each primer mix (10µM)</LI><LI> 10 µL of buffer (5X)</LI><LI> 0,5 µL of Phusion polymerase</LI><LI> 31 µL of nuclease free water</LI><LI> 1.5 µL of DMSO</LI></UL><P>Mix gently and aliquot 50 μl of the mix into the PCR tubes on ice. 
Perform PCR as follow: 
</P><TABLE class="wikitable"><TBODY><TR><TH>Step
</TH><TH>Temperature
</TH><TH>Time
</TH></TR><TR><TD>Initial denaturation
</TD><TD>98°C
</TD><TD>30sec
</TD></TR><TR><TD rowspan="3">30 cycles
</TD><TD>98°C
</TD><TD>10sec
</TD></TR><TR><TD>60°C
</TD><TD>30sec
</TD></TR><TR><TD>72°C
</TD><TD>1 min
</TD></TR><TR><TD>Final Extension
</TD><TD>72°C
</TD><TD>2min
</TD></TR><TR><TD>Hold
</TD><TD>4°C
</TD><TD>$\infty$
</TD></TR></TBODY></TABLE><P><A href="/Team:Paris_Saclay/Experiments#primers" title="Team:Paris Saclay/Experiments">Primers</A> used were:
</P><TABLE class="wikitable"><TBODY><TR><TH>Matrix
</TH><TH>Products from Ligation of gblock 1.1 and gblock 1.2 (fragment 1)
</TH><TH>Products from Ligation of gblock 1.1 and gblock 1.2 (fragment 2)
</TH></TR><TR><TD>Primers
</TD><TD>iPS140 and iPS122
</TD><TD>iPS 123 and iPS84
</TD></TR></TBODY></TABLE><H4><SPAN class="mw-headline" id="Gel_of_PCR_products">Gel of PCR products</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>After amplification, 3 µL of each cleaned up PCR products and 5 µL of DNA ladder were placed in wells and migrated at 100V during 30 min.
</P><P>PCR products expected were :
</P><TABLE class="wikitable"><TBODY><TR><TH>PCR products
</TH><TH>Expected band size (bp)
</TH></TR><TR><TD>Fragment 1
</TD><TD>1920
</TD></TR><TR><TD>Fragment 2
</TD><TD>1831
</TD></TR></TBODY></TABLE><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Result of the migration</DIV></DIV></DIV></DIV><P>A large smearing in agarose gel of PCR products was obtained. As this result was not usable, a new PCR was run by diluting the Ligations products : 1/100, 1/10,000 and 1/1,000,000.
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Result of the migration</DIV></DIV></DIV></DIV><P>A large smearing in agarose gel of PCR products was also obtained, but the smears were seemed to decrease with the dilution rate.
</P></DIV></DIV><DIV class=" footer"><DIV class="container"><DIV class="adress"><ADRESS>Université Paris Sud
91405 Orsay, France</ADRESS></DIV><SMALL class="envers copyright">Copyright © 2016 iGEM Paris Saclay. <STRIKE>All rights reserved</STRIKE> All inspirations encouraged.*This wiki was conceived during long nights of work and a great coffee experience in the beautiful Orsay, France.</SMALL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>